Century Therapeutics, Inc. (IPSC) financial statements and ratios from SEC XBRL: revenue $109.16M (TTM), net margin -8.8%, revenue growth 1556.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $109.16M |
| Net Margin | -8.8% |
| Revenue Growth (YoY) | 1556.8% |
| EPS Growth (YoY) | -91.3% |
| FCF Growth (YoY) | -5.0% |
| Price / Book | 1.61 |
| Price / Sales | 1.14 |
| FCF Yield | -50.0% |
| Altman Z-Score | -0.75 (distress) |
| Sector P/E (Healthcare) | 21.7 |
IPSC overview · IPSC earnings · IPSC KPIs · IPSC investor relations · IPSC ownership · IPSC peers · IPSC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.